The National Institutes of Health (NIH) Awards Another Major Grant to ImmunogenX to Conduct a Clinical Trial for Latiglutenase
The study addresses patients with genetically-linked type 1 diabetes and celiac disease NEWPORT BEACH, Calif.–(BUSINESS WIRE)–The NIH’s National Institute of…